Business · 09/10/2026

European Medicines Agency Proposes Enhanced Evaluation of COVID-19 Vaccines

The European Medicines Agency (EMA) has issued a new proposal for the evaluation of COVID-19 vaccines, following recent concerns over their effectiveness in certain populations. The proposal aims to improve the assessment of vaccine efficacy and safety, and is expected to be discussed by the EMA's Committee for Medicinal Products for Human Use (CHMP) in the coming months.

Source: EMA — Paediatric Investigation PlansOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Business · 10/18/2026

Aura to Release Q3 2026 Earnings Call and Quarterly Results on November 12th

Aura, a global leader in online safety and wellbeing, will release its Q3 2026 financial results on November 12th, 2026, prior to the opening of the ASX market.

Read summary →

Business · 10/18/2026

AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio

AbbVie is set to present new and updated data on its expanding portfolio of treatments for various types of cancer, including lung, colorectal, ovarian, prostate, and gastric cancers, at the 2026 ESMO Congress, showcasing the potential of its next-generation antibody-drug conjugates (ADCs) to address diverse patient needs.

Read summary →

Business · 10/18/2026

Lilly to Showcase Advances Across Its Oncology Pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

Lilly will present early-stage data from its investigational treatments for ovarian cancer and other cancers at the 2026 ESMO Congress, highlighting its oncology pipeline progress.

Read summary →

Business · 10/18/2026

Antibiotic Use in Childhood Linked to Higher Odds of IBS in Young Adulthood, Study Finds

A new study published in Spain found that children who used antibiotics from a young age were more likely to develop irritable bowel syndrome (IBS) by age 24, with the risk increasing with the number of antibiotic prescriptions

Read summary →

Business · 10/18/2026

Antibiotic Use in Childhood Linked to Higher Odds of IBS in Young Adulthood, Study Finds

Read summary →

Business · 10/18/2026

Antibiotic Use in Childhood Linked to Increased Risk of SII in Early Adulthood, Study Suggests

A recent study presented at the UEG Week 2026 conference in Barcelona, Spain, suggests that using antibiotics from a young age may increase the risk of developing SII (a condition) in early adulthood.

Read summary →